Gracell Biotechnologies Inc GRCL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/28/22 EDT
5.09UNCH (UNCH)
Volume
5,547
Close
5.09quote price arrow down-0.05 (-0.97%)
Volume
59,119
52 week range
1.68 - 15.00
Loading...
  • Open5.24
  • Day High5.24
  • Day Low4.92
  • Prev Close5.09
  • 52 Week High15.00
  • 52 Week High Date10/11/21
  • 52 Week Low1.68
  • 52 Week Low Date03/14/22

Key Stats

  • Market Cap70.50M
  • Shares Out13.85M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-15.73

KEY STATS

  • Open5.24
  • Day High5.24
  • Day Low4.92
  • Prev Close5.09
  • 52 Week High15.00
  • 52 Week High Date10/11/21
  • 52 Week Low1.68
  • 52 Week Low Date03/14/22
  • Market Cap70.50M
  • Shares Out13.85M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-15.73

RATIOS/PROFITABILITY

  • EPS (TTM)-1.01
  • P/E (TTM)-5.04
  • Fwd P/E (NTM)-9.88
  • EBITDA (TTM)-59.81M
  • ROE (TTM)-56.43%
  • Revenue (TTM)50,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-111,137.20%
  • Debt To Equity (MRQ)5.76%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gracell Biotechnologies Inc

There is no recent news for this security.

Profile

MORE
Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to deliver younger, less exhausted T cells for autologous cell therapies with...
Address
Building 3
418 Guilin Road, Xuhui District
Shanghai, SHA
200030
China

Top Peers

SYMBOLLASTCHG%CHG
FMTX
Forma Therapeutics Holdings Inc
7.11-0.12-1.66%
BTAI
BioXcel Therapeutics Inc
12.42-0.42-3.27%
HUMA
Humacyte Inc
3.36-0.06-1.75%
PHAT
Phathom Pharmaceuticals Inc
8.20-0.84-9.29%
ALXO
ALX Oncology Holdings Inc
8.06-0.12-1.47%